Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SkinHealth Systems Inc.SKIN · Entity 6863 | Director | July 08, 2024 | July 10, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SkinHealth Systems Inc.
Report date July 08, 2024 · Filed July 10, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 194,341 |
Reported balance
After 2024-07-08 transaction · row 1
1 source rowRow 1 · 2024-07-08 · Grant · Acquired 78,534 · Balance 194,341 F1: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 08, 2024 Filed Jul 10, 2024 20:39 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 78,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-031592 · wk-form4_1720643968.xml · nonDerivative · entry 1 Few Julius · CIK 0001825737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,341 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 17:02 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | PurchaseClass A Common Stock | 20,454 | $6.10 | $124,791.90 |
DisclosureSEC source: 0001628280-23-029955 · wk-form4_1692378147.xml · nonDerivative · entry 1 Few Julius · CIK 0001825737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,807 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:22 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 16,357 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-022521 · wk-form4_1686950566.xml · nonDerivative · entry 1 Few Julius · CIK 0001825737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,450 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| June 28, 2022 Filed Jul 1, 2022 00:10 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 9,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001818093-22-000125 · wf-form4_165663418779681.xml · nonDerivative · entry 1 Few Julius · CIK 0001825737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,093 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 01:23 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 5,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000076 · wf-form4_163166899184498.xml · nonDerivative · entry 1 Few Julius · CIK 0001825737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,160 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the date of the 2022 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the date of the 2022 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| May 14, 2021 Filed Aug 18, 2023 16:58 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherWarrant (right to buy) · Derivative | 66,667 | $1.50 Strike: $11.50 | $100,000.50 |
DisclosureSEC source: 0001628280-23-029952 · wk-form4_1692377914.xml · derivative · entry 2 Few Julius · CIK 0001825737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,667 Underlying: Class A Common Stock · 66,667 shares Expires not disclosed F1 · kind: The reported securities were received in a distribution by BLS Investor Group LLC ("BLS") in accordance with the reporting person's membership interest in BLS, as reported in the issuer's Form S-1 filed with the Securities and Exchange Commission on July 19, 2021. F2 · derivative.exercise_date: The warrants are exercisable by the holder into shares of Class A Common Stock on a one-for-one basis commencing on 10/2/2021, and expire on 5/4/2026 or earlier redemption or liquidation. F2 · derivative.expiration_date: The warrants are exercisable by the holder into shares of Class A Common Stock on a one-for-one basis commencing on 10/2/2021, and expire on 5/4/2026 or earlier redemption or liquidation. Read SEC document |
| May 14, 2021 Filed Aug 18, 2023 16:58 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock | 63,903 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-029952 · wk-form4_1692377914.xml · nonDerivative · entry 1 Few Julius · CIK 0001825737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,353 F1 · kind: The reported securities were received in a distribution by BLS Investor Group LLC ("BLS") in accordance with the reporting person's membership interest in BLS, as reported in the issuer's Form S-1 filed with the Securities and Exchange Commission on July 19, 2021. F1 · price: The reported securities were received in a distribution by BLS Investor Group LLC ("BLS") in accordance with the reporting person's membership interest in BLS, as reported in the issuer's Form S-1 filed with the Securities and Exchange Commission on July 19, 2021. F1 · acquired: The reported securities were received in a distribution by BLS Investor Group LLC ("BLS") in accordance with the reporting person's membership interest in BLS, as reported in the issuer's Form S-1 filed with the Securities and Exchange Commission on July 19, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.